ATC Group: R03AK06 Salmeterol and fluticasone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03AK06 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R03 Drugs for obstructive airway diseases
3 R03A Adrenergics, inhalants
4 R03AK Adrenergics and other drugs for obstructive airway diseases
5 R03AK06 Salmeterol and fluticasone

Related product monographs

Title Information Source Document Type  
SALMEX Inhalation powder, pre-dispensed Medicines Authority (MT) MPI, EU: SmPC
SEREFLO Pressurised inhalation, suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SERETIDE Inhaler Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.